The interferon beta (IFN-β), 1A and 1B, represents the first widely used DMTS, and it is still one of the most commonly administered drugs for the treatment of the relapsing-remitting MS (RRMS) variant [4]. The gene discussed is IFNB1; the disease is relapsing-remitting multiple sclerosis.